Question 1

What are the potential side effects of ERB-041?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women clinical trial (NCT00318500). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women clinical trial (NCT00318500). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment visits involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women clinical trial (NCT00318500). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women clinical trial (NCT00318500). Contact the study team or your healthcare provider for specific answers.

Question 5

Will I receive a placebo, and how will that affect my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women clinical trial (NCT00318500). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if my symptoms do not improve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women clinical trial (NCT00318500). Contact the study team or your healthcare provider for specific answers.

What this study is about